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AP-1Hernia is a disease with defects in collagen synthesis/metabolism. However, the underlying mechanisms for
hernia formation have not been fully deﬁned. Tamoxifen is a selective estrogen receptor modulator and used
for patients with breast cancer. Tamoxifen also has pleiotropic and side effects. Herein, we report that tamoxifen
treatment resulted in an appearance of a large bulge in the low abdomenbetween the hind legs inmale but not in
femalemice. The autopsy demonstrated that the low abdominal wall was broken and a large amount of intestine
herniated out of the abdominal cavity. Histological analysis indicated that tamoxifen caused structural abnormalities
in the low abdominal wall which were associated with decreased type II collagen content. Furthermore, we
determined increased matrix metalloproteinase-2 (MMP-2) and MMP-13 expression in the tissue. In vitro,
tamoxifen induced MMP-2 and MMP-13 expression in ﬁbroblasts. The promoter activity analysis and ChIP assay
demonstrate that induction of MMP-13 expression was associated with activation of JNK–AP-1 and ERK1/2
signalingpathwayswhile inductionofMMP-2 expressionwas related to activationof the ERK1/2 signalingpathway.
Taken together, our study establishes a novel murine hernia model, deﬁnes a severe side effect of tamoxifen, and
suggests a caution to male patients receiving tamoxifen treatment.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Hernia occurs when tissue structure and function are lost at the
load-bearing muscle, tendon and fascial layer. It might be the result of
endogenous and/or exogenous risk factors, such as a genetic predisposi-
tion, cigarette smoking, abnormal collagen isoforms and matrix metal-
loproteinase (MMP) expression in the tissue [1]. Most of hernias occur
at the abdominal wall area with the appearance of a bulge and a major-
ity of inguinal hernias. The loss of themechanical integrity of abdominal
wall structural tissues in hernia patients results in a variety of symptoms
including groin pain, genital pain, urinary symptoms, abdominal pain,
increased peristalsis and tenesmus. Although hernia is not a life-threat-
ening disease, it is the third most important cause of patients requiring
hospital emergency services due to a gastrointestinal pathology [2].
Surgery is usually recommended for treatment of hernias. For instance,receptor; ERK1/2, extracellular
ase; JNK, c-JunN-terminal kinase
nkai University, 94Weijin Road,
, jihonghan2008@nankai.edu.cnthe inguinal hernia repair is one of the most common operations per-
formed by general surgeons. The repair is a safe and straightforward
procedure with satisfactory results generally. However, patients may
experience a slow postoperative recovery and delayed return to work.
The methods for repair of inguinal hernia include traditional tissue-
based and tension-free mesh-based techniques [3]. The excessive
suture-line tension by traditional tissue-based repairs can result in a
high recurrence rate and signiﬁcant postoperative pain. In contrast,
the newly developed open and laparoscopic mesh-based repairs signif-
icantly reduce the recurrence rate and decrease the length of hospital
stay. However, the insertion of a piece of mesh prosthesis, which is
made of polyester, polypropylene or polytetraﬂuoroethylene, may
cause infection, rejection as well as hernia recurrence [4].
The fundamental mechanisms responsible for hernia formation still
need more investigation. However, both clinical and basic research re-
sults indicate that the abnormal collagen synthesis and/or metabolism
may play an important role in the pathological procedure of hernias
[5–8]. Collagen is an important structural protein of connective tissues
and a major component of the extracellular matrix (ECM). It comprises
about 80% structural tissue dry weight and is critical to the tensile
strength in abdominalwall fascial layers. Fibroblast is themost common
cell type which is responsible for collagen synthesis and metabolism.
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lated by activities of MMPs which result in altered collagen degradation
[9]. In fact, both increasedMMP-2 andMMP-13 have been implicated in
hernia formation [8,10].
Tamoxifen is a selective estrogen receptor modulator (SERM) and
used to treat patients with breast cancer [11]. Based on the cell types
and tissues, tamoxifen can function either as an agonist or an antagonist
of estrogen receptor (ER) [12]. Tamoxifen also has atheroprotective ef-
fects which have been determined in both animal models and humans
[13–16]. We previously reported that tamoxifen increased expression
of type BI scavenger receptor (SR-BI), a receptor for high-density lipo-
protein, in macrophages isolated from female but not male mice [17].
The induction of SR-BI expression in a sex-dependent manner indicates
that tamoxifen may have different functions or side effects between
males and females. In addition, our preliminary study demonstrated
that tamoxifen treatment induced a visible protrusion in the bottom
area of the low abdomen between the hind legs in male but not female
apoE deﬁcient (apoE−/−) mice implying that tamoxifen may inﬂuence
collagen synthesis/metabolism and the development of hernia. Estro-
gen and its analogs have been reported to induce mouse inguinal and
scrotal hernias. However, the method results in a low morbidity of
hernia and a high mortality in the animals [18]. In this study, we deter-
mined if tamoxifen can induce hernia formation in a safe and reliable
manner and the underlying mechanisms.
2. Materials and methods
2.1. Reagents
Tamoxifen, SP600125 and U0126 were purchased from Cayman
Chemical (Ann Arbor, MI). Rabbit anti-mouse MMP-13 polyclonal anti-
body was purchased from Novus Biologicals (Littleton, CO). Rabbit
anti-mouse COL2A1, MMP-2, ERK1/2, pi-ERK1/2, ERα and ERβ poly-
clonal antibodies, and goat anti-mouse COL1A2 and COL3A1 polyclonal
antibodies were purchased from Santa Cruz Biotechnology (Dallas,
Texas). Anti-pi-c-Jun, JNK, and pi-JNK polyclonal antibodies were
purchased from Immunoway (Newark, DE). All chemicals were
purchased from Sigma-Aldrich (St Louis, MO) except as indicated.
2.2. Cell culture and animals
NIH3T3 cells, amouse ﬁbroblast cell line, were purchased fromATCC
(Rockville, MD) and cultured in complete DMEM medium containing
10% fetal calf serum, 50 μg/ml penicillin and streptomycin, and 2 mM
glutamine. Cells received tamoxifen treatment in serum-free medium
when the conﬂuence was ~90%. All reagents were dissolved in DMSO
and dilutedwith PBS (1:200) just prior to treatment. Cells in the control
group received an equal volume of solvent (0.5% DMSO in PBS)
treatment.
The normal chow of “2014 global 14% protein rodent diet” contains
the following ingredients: wheat midds, ground wheat, ground corn
and corn gluten meal. Totally, 14.0% protein and 4.0% fat (soybean oil)
were contained in the normal chow with metabolizable energy of
2.9 kcal/g. The high-fat diet (HFD) contains 0.5% cholesterol and 21%
fat. The protocol for animal study was approved by the Animal Ethics
Committee of Nankai University. Both wild type C57BL/6 and apoE deﬁ-
cient (apoE−/−, C57BL/6 background) mice (~10-weeks-old, both
males and females) were purchased from the Animal Center of Nanjing
University (Nanjing, China) and maintained in the Animal Center of
Nankai University (Tianjin, China). The animals were always free to
access food and water. When animals received treatment, they were
randomly divided and then fed either normal chow or HFD or the diet
containing tamoxifen (2 mg/100 g food). During the treatment, all
the mice were daily checked for the appearance of bulges at the low
abdomen between the hind legs. At the end of experiments, mice
were anesthetized and euthanized in a CO2 chamber followed byautopsy of the hernia region with photographs and collection of tissue
samples (the broken low abdominal wall, rib, ear and lung).
2.3. Hematoxylin–eosin and picro-sirius red staining
To analyze the effect of tamoxifen treatment on structure and colla-
gen content, the broken low abdominal wall samples from male mice
receiving tamoxifen treatment or the corresponding area from male
mice in the control group were collected, ﬁxed in 4% paraformalde-
hyde/PBS, and embedded in parafﬁn. The 5 μm parafﬁn sections were
collected and used to conduct hematoxylin–eosin (HE) staining initially
as follows: the sections were deparafﬁnated in xylene (2 × 5 min) and
rehydrated in 100, 95, 90, 80 and 70% ethanol for 5 min each. The sec-
tions were then stained in a hematoxylin solution (purchased from
Sigma-Aldrich) for 5 min, rinsed with distilled water (2 × 5 min), and
stained in eosin solution (purchased from Sigma-Aldrich) for 4 min
followed by dehydration with successive 5 min washes in 70, 80, 90,
95 and 100% ethanol, and xylene (2 × 5 min).
The picor-sirius staining was used to determine collagen content as
follows: the parafﬁn sections were de-waxed and rehydrated through
gradient alcohol solutions to water as described above, then stained nu-
clei with hematoxylin solution for 8min. After threewasheswithwater,
the sectionswere stained with picro-sirius red solution [0.1% Direct Red
80 in saturated aqueous picric acid (~1.2% picric acid in water)] for 1 h.
The sections were then washed twice with acidiﬁed water (0.5% acetic
acid, v/v), and dehydrated by three times of immersion in 100% ethanol
and two times in xylene.
After staining, all the sectionsweremounted under cover slideswith
Permount, observed and photographed with a microscope.
2.4. Isolation of total RNA and real time RT-PCR analysis of MMP-2 and
MMP-13 mRNA expression
After treatment a piece of tissue was homogenized or cells were
directly lysed in RNAzol™ B (Tel-Test, Inc., TX). The lysate was mixed
well with chloroform and centrifuged for 15 min at 13,000 rpm at 4 °C
with a Microfuge. The top aqueous phase, which contains total cellular
RNA, was collected and mixed with an equal volume of isopropanol to
precipitate the total cellular RNA. The cDNA was synthesized with 1 μg
of total RNA using TransScript First-Strand cDNA Synthesis Supermix
purchased from New England Biolabs (Ipswich, MA). Real time PCR
was performed using the SYBR green PCR master mix (Bio-Rad, Los
Angeles, CA) with the following primers: MMP-2 forward: 5′-TGGCAA
GGTGTGGTGTGCGAC-3′, and backward: 5′-TCGGGGCCATCAGAGCTC
CAG-3′; MMP-13 forward: 5′-TCTGGTCTTCTGGCACACGCT-3′, and
backward: 5′-GGCCAAGCTCATGGGCAGCAA-3′; and GAPDH forward:
5′-ACAACTTTGGCATTGTGGAA-3′, and backward: 5′-GATGCAGGGATG
ATGTTCTG-3′. MMP-2 or MMP-13 mRNA expression was normalized
by the corresponding GAPDH mRNA.
2.5. Western blot analysis of collagen and MMP expression and
zymography analysis of MMP-2 activity
After treatment, a piece of tissue (~50 mg) was homogenized (the
cell samples were directly lyzed) with a lysis buffer (20 mM Tris,
pH 7.5, 137 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1% sodium
deoxycholate, 25 mM β-glycerophosphate, 2 mM sodium pyrophos-
phate, 1 mM phenylmethylsulfonyl ﬂuoride, 10 μg/ml aprotinin and
100 mM NaVO4) [17]. The homogenate or cellular lysate was centri-
fuged for 10 min at 13,000 rpm at 4 °C, and the supernatant as whole
protein extract was collected. Protein (40 μg/sample) from each sample
was loaded and separated on a SDS–polyacrylamide gel and transferred
onto a nitrocellulose membrane. The membrane was blocked with 5%
non-fat dry milk in PBS for 1 h at room temperature (RT), and then in-
cubated with primary antibody in 1% dry fat-free milk/PBS overnight
at 4 °C followed by washing for 3 × 5 min with PBS containing 0.5%
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conjugated goat anti-rabbit or rabbit anti-goat IgG for 1 h at RT. After
being washed for 3 × 5 min with PBS-T, the membrane was incubated
for 4 min in a mixture of equal volumes of Western blot chemilumines-
cence reagents A and B. The membrane was then exposed to ﬁlm and
developed.
Activity of MMP-2 was determined by zymography assay [19]. After
treatment the culture medium was loaded on a SDS–polyacrylamide
(10%) gel containing 1% gelatin. After electrophoresis, the gelwaswashed
with renaturing buffer (2.5% Triton X-100, 50mMTris–HCl, pH 7.6, 5mM
CaCl2, 1 μM ZnCl2) for 2 × 30 min to remove SDS, then with a buffer
containing 50 mM Tris–HCl, pH 7.4, 5 mM CaCl2 and 1 μM ZnCl2 for
2 × 20 min followed by incubation in the developing buffer (50 mM
Tris–HCl, pH 7.5, 5 mM CaCl2, 1 μM ZnCl2, 0.02% NaN3) for 36 h at 37 °C.
The gel was then stained with 1% Coomassie Blue R250 and the image
was captured with a gel image system (GBOX, SYNGENE).
2.6. Immunohistochemistry
The 5 μm parafﬁn sections of the broken or normal low abdominal
wall were incubated in PBS containing 0.1% Triton X-100 for 10 min
followed bywashwith PBS (2 × 5min). The endogenous peroxidase ac-
tivity was blocked by incubating in 3% H2O2 solution for 10 min. After
three washes with water, the sections were heated in a sodium citrate
solution (0.01M, pH 6.0) for 20min in a 95 °Cwater bath to retrieve an-
tigen, and then blocked with goat serum (37 °C, 10 min) to suppress
nonspeciﬁc background staining. The sections were incubated with
anti-MMP-2 or MMP-13 antibody overnight at 4 °C followed by incuba-
tion with biotinylated goat anti-rabbit IgG (working ﬂuid) for 15 min
and then with avidin–biotin–HRP complex for 15 min at RT. After
rinse with PBS, the sections were exposed to 0.04% diaminobenzidine
tetrahydrochloride (DAB) for 5–10min and counterstained with hema-
toxylin for nuclei. At last, the sections were dehydrated in alcohol,
mounted under cover slides with Permount, and then viewed and
photographed under a microscope.
2.7. Preparation of plasmid DNA and determination of MMP-13 promoter
activity
A natural mouse MMP-13 promoter (from−321 to +50) was con-
structed by PCR with mouse genomic DNA and the following primers:
forward, 5′-CCGGGTACCCTGAAAAACTCAGAGTAGCTG-3′; backward,
5′-CCGCTCGAGTGAATGCATGGTGCCCAGC-3′. After the sequence was
conﬁrmed, the PCR product was digested with XhoI and KpnI, and
then ligated into pGL4 luciferase reporter vector, transformed, and
ampliﬁed (pMMP-13).
The MMP-13 promoter with AP-1 site mutation (from−31 to−25
with a sequence of TGAcTCA, pMMP-13-AP1mu) was constructed
using the Phusion Site-DirectedMutagenesis Kit (New England Biolabs)
with the naturalMMP-13 promoter and the following primers: forward,
5′-aagtggTGAcATCtcactatc-3′ [the conserved AP-1 sequence is
TGAsTCA (s = g or c), the last three nucleotides of TCA in the AP-1 site
of MMP-13 promoter were replaced by ATC (underlined)]; backward,
5′-gatagtgaGATgTCAccactt-3′.
To analyze promoter activity, about 95% conﬂuent NIH3T3 cells in
48-well plates were co-transfected with the DNA for the MMP-13 pro-
moter and Renilla (for internal normalization) using Lipofectamine™
2000 (Invitrogen). After 4 h of transfection, the cells received the indi-
cated treatment for 8 h. The cells were then lysed and the cellular lysate
was used to determine activity of ﬁreﬂy and Renilla luciferase using the
Dual-Luciferase Reporter Assay System (Promega, Madison, WI).
2.8. Inhibition of ER or c-Jun expression by siRNA
ERα, ERβ or c-Jun siRNAwas purchased from Santa Cruz Biotechnol-
ogy (Dallas, TX). The transfection of NIH3T3 cells with siRNA wascompleted by electroporation with the Bio-Rad Gene Pulser Xcell™
machine. After 24 h of transfection, cells were switched to complete
mediumand culturewas continued for 36h followed by treatment over-
night. Expression of ERα, ERβ, pi-c-Jun andMMP-13was determined by
Western blot, respectively.
2.9. ChIP assay of the binding of pi-c-Jun with AP-1
To determine the binding activity of AP-1 complexwith the AP-1 site
in theMMP-13 promoter, after treatment the cells were cross-linked by
the addition of formaldehyde followed by sonication in a lysis buffer
(50 mM Hepes–KOH, pH 7.5, 140 mM NaCl, 1% Triton X-100, 1 mM
EDTA, 0.1% sodium deoxycholate, 0.1% SDS and protease inhibitors
aprotinin/leupeptin) to fragment cellular DNA into an average size of
500–1000 bp. The input PCR was conducted with DNA extracted from
the sonicated chromatin after reversal of the cross-linking. The immu-
noprecipitation was conducted with the same amount of chromatin
from each sample based on the input and by anti-pi-c-Jun or anti-Myc
polyclonal antibody separately, followed by PCR. The PCR primers
were: AP-1 (from −50 to +141, the product was 191 bp), 5′-
atttccctcagattctgcc-3′ (forward) and 5′-tgaatgcatggtgcccagc-3′ (reverse);
and Myc (from −591 to −505, the PCR product was 87 bp), 5′-
tacccacctcgcttcaagga-3′ (forward) and 5′-cactgtagatgattgagtcct-3′
(reverse), respectively.
2.10. Data analysis
All experimentswere repeated at least three times and the represen-
tative results were presented. The data of real time RT-PCR and promot-
er activity were presented as means ± SEM and analyzed by Student's
t-test (n ≥ 3), respectively. The signiﬁcant difference was considered if
P b 0.05.
3. Results
3.1. Tamoxifen induces hernia formation in male mice
To determine if administration of tamoxifen can induce the develop-
ment of hernia in a sex-dependent manner, both male and female wild
typemicewere randomly divided into two groups and fed normal chow
or plus tamoxifen (2 mg/100 g food). After initiation of the treatment,
the exterior appearance of all the animals was checked daily. At the
end of the treatment (~5 weeks), male mice which were fed normal
chow alone appeared normal. In contrast, all male mice receiving ta-
moxifen treatment had a big bulge in the low abdomen (lower left
panel, Fig. 1A, the circled area) between the hind legs. The results of an-
atomical analysis suggest that the bulgewasdue to hernia formation be-
cause the bottom area of the low abdominal wall was broken (lower
middle panel, Fig. 1A, the circled area) and both large and small intes-
tines herniated out from the abdominal cavity (indicated by red and yel-
low arrows, lower right panel, Fig. 1A). Compared to male mice, all
female mice which were fed normal chow or plus tamoxifen did not
have any protrusion in whole abdomen while anatomical results ap-
peared normal (Fig. 1B). Therefore, administration of tamoxifen leads
to the development of hernia inmice in a sex-dependentmanner. How-
ever, tamoxifen treatment did not cause death and difference in food in-
take and body weight gain in both male and female mice.
3.2. Tamoxifen causes structural abnormalities in the low abdominal wall
by reducing collagen content
Hernia is the disease of the extracellular matrix (ECM) which is due
to the disorders in collagen synthesis/metabolism. Treatment of male
mice with tamoxifen resulted in rupture in the bottom area of the low
abdominal wall, which indicates that tamoxifen may cause structural
abnormalities in the tissue by altering collagen synthesis/metabolism.
Fig. 1. Tamoxifen induces hernia formation inmale C57BL/6 wild type mice. Bothmale and female C57BL/6 wild type mice were divided into two groups (10mice/group) and fed normal
chow or plus tamoxifen (2 mg/100 g food) for 5 weeks. After two weeks of the treatment, all male mice receiving tamoxifen treatment had bulges at the low abdomen. At the end of
experiment, all the mice were euthanized followed by autopsy, photograph and collection of tissue samples. A: the representative images of anatomical results of male mice in control
and tamoxifen groups. Lower panel: the area hernia occurred was circled by red line. The yellow and red arrows indicate the herniated out large and small intestines, respectively; B:
the representative images of anatomical results of female mice in control and tamoxifen groups.
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receiving tamoxifen treatment and the tissue at the same site from con-
trol mice were collected and 5 μm sections were prepared. The sections
were initially used to conduct hematoxylin–eosin (HE) staining. As
shown in Fig. 2A, a compact rectus sheet was determined in control
mice (upper panel). In contrast, the tissue from mice receiving tamoxi-
fen treatment displays a loosen or irregularly arranged structure which
might be due to the shrinking of myoﬁbers. In addition, formation of
dehiscences between myoﬁbers and more inﬁltrating white cells
(indicated by the black arrows in the inserted ﬁgures of the right
column, Fig. 2A) in the tissue were determined by tamoxifen treatment
(lower panel). Therefore, tamoxifen treatment causes structural abnor-
malities in the bottom area of the low abdominal wall.
We next determined if the structural abnormalities are because of
changes in collagen content. Similar to HE staining, the results of
picro-sirius red staining demonstrate a continuous rectus sheet in con-
trol mice while a loosen sheet with broken area (Fig. 2B, the area
surrounded by a black dotted line and indicated by the black arrows
in the squares) in mice receiving tamoxifen treatment was determined.
The reduced density of picro-sirius red staining also suggests that
tamoxifen treatment decreased collagen content in the tissue.
The effect of tamoxifen treatment on collagen content in the low
abdominal wall was further determined by Western blot analysis.The results in Fig. 2C and E show that tamoxifen slightly increased
both pre-mature and mature forms of the collagen IA2 while slightly
decreased collagen IIIA1. However, the results in Fig. 2D demonstrate
that expression of collagen IIAwas substantially decreased by tamoxifen
treatment (upper panel). The immunohistochemical staining also
conﬁrms reduced collagen IIA in the rectus sheet by tamoxifen. The
decreased collagen IIA content may cause the structural abnormalities
in the bottom area of the low abdominal wall which can contribute to
hernia formation.
3.3. Tamoxifen treatment activates MMP-2 and MMP-13 expression
The decreased collagen IIA content might be due to collagen degra-
dation by increased MMPs in the tissue. Both MMP-2 expression and
MMP-13 expression have been implicated in hernia formation. MMP-
13 plays a dominant role while MMP-2 is also involved in the degrada-
tion of collagen II [5,20]. We initially determined the effect of tamoxifen
treatment on MMP-2 expression. Fig. 3A demonstrates that tamoxifen
induced MMP-2 mRNA expression in the broken low abdominal wall.
Consistently, the results of Western blot (Figs. 3B) show that MMP-2
protein expression was induced by tamoxifen treatment while immu-
nohistochemical staining (Fig. 3C) conﬁrms increased MMP-2 expres-
sion in the tissue.
Fig. 2. Tamoxifen treatment decreases collagen II content in the bottom area of the low abdominal wall. A piece of the low abdominal wall frommalemice receiving tamoxifen treatment
(broken) and control male mice (normal) in Fig. 1A was individually collected. The samples were used to prepare 5 μm sections or extract total protein for following analysis. A: HE
staining. The black arrows in the inserted ﬁgures (right lower corner) indicate the inﬁltrating white cells; B: picro-sirius red staining (the typical dehiscence formed in the tissue was
labeled by dotted line and indicated by arrows in the squared area); C, E: Western blot analysis of COL1A2 and COL3A1 expression; D: Western blot and immunohistochemical staining
analysis of COL2A1 expression. *: vs. control, P b 0.05 (n = 3).
Fig. 3. Tamoxifen induces MMP-2 expression in the broken area of the low abdominal
wall. The broken or normal piece of the low abdominal wall was collected from the
mice in Fig. 1A and used to extract total RNA and protein or prepare 5 μm sections for
the following assays. A, B: expression of MMP-2 mRNA and protein was determined by
real time RT-PCR and Western blot, respectively; *: vs. control, P b 0.05 (n = 3); C:
MMP-2 protein expression was determined by immunohistochemical staining.
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(Fig. 4A). Both Western blot (Fig. 4B) and immunohistochemical stain-
ing (Fig. 4C) demonstrate that tamoxifen treatment induced MMP-13
protein expression in the broken area of the low abdominal wall. Rib
is another tissue which is rich in collagen content and MMP-13 activity.
MMP-13 expression in this tissue was also induced by tamoxifen
(Fig. 4D). However, little change was observed in mouse ear and lung
(Fig. 4E) suggesting that the regulation of MMP-13 expression by
tamoxifen is in a tissue-dependent manner.
To determine if the induction of MMP-2/13 expression in the low
abdominal wall is also in a sex-dependent manner which can be corre-
lated to hernia formation, both male and female wild type mice were
fed normal chow or plus tamoxifen or estrogen for 3 weeks (estrogen
was used as a negative control). Once again, we determined that hernia
occurred to all male mice receiving tamoxifen treatment, not male mice
fed chow alone. Both male and female mice receiving estrogen treat-
ment appeared normal. The samples of the broken or normal area of
the low abdominal wall from all mice were collected and used to deter-
mineMMP-2/13 expression. The results of immunohistochemical stain-
ing (Fig. 5A) demonstrate that tamoxifen increased both MMP-2 and
MMP-13 expression in male mice while slightly decreasing them in
female mice. In contrast, estrogen moderately reduced MMP-2 and
MMP-13 expression in both male and female mice.
The induction of MMP-2 and MMP-13 expression by tamoxifen in a
sex-dependent manner was also conﬁrmed by Western blot analysis.
Fig. 4. Tamoxifen inducesMMP-13 expression inmouse low abdominalwall and rib. In addition to the broken area of the low abdominal wall, mouse rib, lung and ear were collected from
malemice in Fig. 1A andused to conduct the following assays. A–C: expression ofMMP-13mRNAor protein in the low abdominalwallwas determinedby real time RT-PCR (A) orWestern
blot (B) and immunohistochemical staining (C). *: vs. control, P b 0.05 (n= 3). Arrows indicate ﬁbroblast-rich areas (C); D, E: expression of MMP-13 protein in mouse rib (D) or ear and
lung (E) was determined byWestern blot.
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mice (left panel, Fig. 5B) and increased in male mice (right panel,
Fig. 5B) by tamoxifen treatment, respectively. The results in Fig. 5B
also demonstrate that estrogen had moderate reductive effects on
MMP-2 and MMP-13 expression in all animals.
3.4. Induction ofMMP-13 expression by tamoxifen is related to activation of
JNK–AP-1 and ERK1/2 signaling pathways
Our above results demonstrate that tamoxifen decreases collagen
content while activating MMP-2/13 expression, which indicates that
the degradation of collagen II should be enhanced. The degradation of
collagen II ismainly regulated byMMP-13 activitywhileMMP-2 activity
is also involved [5,20]. Fibroblast is the main cell type to generate
collagen. Therefore, we used NIH3T3 cells, a mouse ﬁbroblast cell line,
to determine the involved molecular mechanisms by in vitro ex-
periments. We initially and primarily focused on the regulation of
MMP-13 expression by tamoxifen. Treatment of NIH3T3 cells with ta-
moxifen induced MMP-13 protein expression in a semi-concentration
dependentmanner (Fig. 6A). Associated with increased protein expres-
sion, tamoxifen induced MMP-13 mRNA expression (Fig. 6B) which
indicates that the induction may be completed at the transcriptional
level.
Several transcription factors are involved in MMP-13 transcription,
such as activator protein-1 (AP-1) complex and estrogen receptor
(ER). Tamoxifen induces hernia formation in male but not female mice
implying that ER activity does not play an important role in tamoxifen-
regulated MMP-13 expression. To conﬁrm it, expression of ER in
NIH3T3 cells was blocked by transfection of ERα/β siRNA, and then the
cells were treated with tamoxifen. Compared to cells transfected with
scrambled siRNA, tamoxifen still induced MMP-13 expression in the
ERα/β siRNA transfected cells to a similar degree (Fig. 6C) suggesting
that induction of MMP-13 expression by tamoxifen does not require
the existence of ER expression in the cells.AP-1 is a transcription factor complex which is a heterodimeric pro-
tein composed of c-Fos and c-Jun. Activation of AP-1 requires phosphor-
ylation of c-Jun (pi-c-Jun) by the c-Jun N-terminal kinase (JNK) [21,22].
Both AP-1 and JNK can induce MMP-13 expression [23–25]. To deter-
mine the role of the JNK–AP-1 signaling pathway in tamoxifen-
induced MMP-13 expression, we constructed a normal MMP-13
promoter and a MMP-13 promoter with AP-1 site mutation. Tamoxifen
activated the normalMMP-13 promoter (left panel, Fig. 6D). In contrast,
mutation of the AP-1 site in the promoter substantially reduced the
basal levels, and blocked the induction of promoter activity by tamoxi-
fen (right panel, Fig. 6D) indicating an important role of AP-1 in
tamoxifen-induced MMP-13 transcription.
We further determined if tamoxifen treatment can enhance theDNA
binding activity of pi-c-Jun protein with AP-1motif in theMMP-13 pro-
moter. The results of ChIP assay (Fig. 6E) show that tamoxifen increased
the formation of the pi-c-Jun protein/AP-1 motif complex. In addition,
when expression of c-Jun was selectively inhibited by c-Jun siRNA, the
phosphorylation of c-Jun (pi-c-Jun) and induction of MMP-13 expres-
sion, which can be determined in scrambled siRNA transfected cells
(Fig. 6F, left half), were blocked (Fig. 6F, right half).
Correspondingly, we determined that although JNK expression was
little affected, phosphorylation of JNK (pi-JNK) was quickly induced by
tamoxifen (Fig. 7A) which results in increased pi-c-Jun (Fig. 6F).
Although SP600125 (a JNK inhibitor) alone had little effect on MMP-13
expression, it substantially reduced the induction of MMP-13 expression
by tamoxifen (Fig. 7B).
Expression ofMMP-13 can also be inﬂuencedbyERK1/2 activity [26].
To determine if the ERK1/2 signal pathway is also involved in tamoxifen-
induced MMP-13 expression, we treated NIH3T3 ﬁbroblasts with
tamoxifen and determined that tamoxifen had little effect on ERK1/2
expression while increasing ERK1/2 phosphorylation (pi-ERK1/2)
quickly (Fig. 7C). In the presence of an ERK1/2 inhibitor (U0126), the
induction of MMP-13 expression by tamoxifen was also partially
reduced (Fig. 7D). Thus, the co-treatment of the cells with SP600125
Fig. 5. Tamoxifen induces MMP-2 andMMP-13 expression in the low abdominal wall in a sex-dependent manner. Both female andmale C57BL/6 wild type mice were randomly divided
into three groups (3/group) and fed normal chow (Ctrl) or plus tamoxifen (2 mg/100 g food, Tam) or estrogen (0.8 mg/100 g food, E2, negative control) for 3 weeks. A piece of the low
abdominal wall where hernia occurred or the corresponding piece was collected frommale mice receiving tamoxifen treatment or frommice in other groups. Expression of MMP-2 and
MMP-13 was determined by immunohistochemical staining (A) and Western blot (B), respectively.
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tamoxifen (Fig. 7E) indicating that the induction of MMP-13 expression
by tamoxifen is related to activation of both the JNK–AP-1 and ERK1/2
signaling pathways.
We also determined the signaling pathway by which tamoxifen
induced MMP-2 expression. Treatment of NIH3T3 cells with tamoxifen
induced both MMP-2 mRNA and protein expression (Fig. 8A and B).
Functionally, in the gelatin zymography assay, the culture medium
from the cells receiving tamoxifen treatment caused more gelatin deg-
radation than themedium from control cells (Fig. 8C) indicating the en-
hanced collagenase enzymatic activity by tamoxifen treatment. The
presence of an ERK1/2 inhibitor (U0126, Fig. 8D), but not a JNK inhibitor
(SP600125, Fig. 8E), blocked the induction of MMP-2 expression
(Fig. 8D) suggesting that the ERK1/2 signaling pathway is also involved
in, while the JNK–AP-1 signaling pathway had little effect on, the
tamoxifen-induced MMP-2 expression.
4. Discussion
The abnormal collagen metabolism is believed as an early biological
mechanism for the development of primary hernias in humans. In this
study, we also determined that associated with tamoxifen-induced
hernia in male wild type mice, the collagen content, particularly the
collagen type II, in the bottom area of the low abdominal wall wherethe hernia occurred was reduced, while expression of MMP-2 and
MMP-13 in the tissue was increased (Figs. 2–5). These changes are in
a sex dependent manner and well correlate to hernia formation in
male but not female mice (Fig. 1).
Cigarette smoking and mechanical strain are considered as the
exogenous risk factors for the development of hernia. Compared to ta-
moxifen contained in normal chow, we determined that tamoxifen
contained in a high-fat diet induced hernia occurrence faster. Mean-
while, tamoxifen also induced the occurrence of hernia faster in apoE
deﬁcient mice than wild type mice (Fig. 9). These results may imply
the involvement of increased cholesterol levels in the hernia pathologi-
cal process. Although the direct link between hernia and cholesterol
levels has never been reported, the levels of MMPs can be increased
by hypercholesterolemia while decreased by statins, the cholesterol-
lowering medicine [27–29].
The mechanisms responsible for incisional hernia formation have
been intensively investigated. The increased soluble (immature) colla-
gen and MMP levels, and decreased ratio of type I:type III collagen
have been found in the tissue from human incisional hernia [30,31].
We also determined increased MMP-2 and MMP-13 expression in the
tissue from tamoxifen-induced hernia. However, the levels of collagen
type I and type III (Fig. 2C and E) were moderately affected while colla-
gen type II was decreased which indicates that the changes in collagen
might be dependent on hernia types or species. Collagen type II is
Fig. 6. Induction of MMP-13 expression by tamoxifen is associated with activation of AP-1. A, B: NIH3T3 cells, a mouse ﬁbroblast cell line, in serum-free medium were treated with
tamoxifen at the indicated concentrations for 8 and 4 h followed by determination ofMMP-13 protein (A) andmRNA (B) expressionwithWestern blot and real time RT-PCR, respectively.
*: vs. control, P b 0.05 (n = 3); C: NIH3T3 cells were transfected with scrambled siRNA or a mixture of ERα and ERβ siRNA (50 nM of each) followed by treatment with tamoxifen.
Expression of ERα, ERβ and MMP-13 was determined by Western blot; D: NIH3T3 cells were transfected with DNA of the natural MMP-13 promoter (left panel) or the promoter with
AP-1mutation (right panel) plus Renilla luciferase (for internal normalization) followed by treatment with tamoxifen overnight. The cellular lysate was extracted and used to determine
activities of ﬁreﬂy and Renilla luciferases. #: vs. control, P b 0.05 (n=3); E: NIH3T3 cells were treatedwith 4 μM tamoxifen overnight. After treatment, chromatinwas isolated followed by
immunoprecipitation with normal IgG or anti-pi-c-Jun antibody. The PCR was conducted with the primers for AP-1 in the MMP-13 promoter. *: the chromatin from samples
immunoprecipitated by anti-Myc antibody was used to conduct PCR with the primers for Myc (from−591 to−505) in the MMP-13 promoter; F: NIH3T3 cells were transfected with
scrambled or c-Jun siRNA followed by treatment with tamoxifen. Expression of pi-c-Jun and MMP13 was determined by Western blot.
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homeostasis of collagen type II is mainly regulated by MMP activity, in
particular, by MMP-13 because MMP-13 induces cleavage of collagen
type II 5–6 times faster than collagen type III or type I [20]. Accordingly,
we determined the induction of MMP-13 expression by tamoxifen in
the low abdominal wall where the hernia occurred (Figs. 4 and 5). In
addition, we determined expression of collagen type II inmouse tissues,
and found that collagen type II was expressed in the rib, abdominal wall
and lung with most in the abdominal wall while it was undetectable in
muscle and ear (data not shown). Taken together, our results suggest
that collagen type II may also play an important role in the integrity of
the abdominal wall and hernia formation.
Tamoxifen is a medicine used to treat patients with breast cancer
which rarely occurs in men. However, the majority of male breast can-
cer cases express female-related hormone receptors [35] which leads
to the application of tamoxifen treatment to male breast cancer
patients. In addition, tamoxifen plays an important role in ﬁghting
other diseases, such as osteoporosis, rheumatoid arthritis, autoimmune
diseases, bipolar disorders and cardiovascular disease which suggests
that tamoxifen might be used by both female and male patients.
However, action of tamoxifen on these diseases can be completed byER-independent mechanisms. For instance, tamoxifen reduces the inci-
dence of fatal myocardial infarction and the intima–media thickness of
the common carotid artery in postmenopausal women. It also increases
the endothelium-dependent ﬂow-mediated dilation (ED-FMD) in men
with advanced atherosclerosis [16,36,37]. In animal models, tamoxifen
reduces atherosclerosis in both male wild type and apoE−/−mice and
surgically postmenopausal monkeys [13,14,38]. In spite of the potential
broad range of application, several deleterious effects of tamoxifen have
been reported [39]. Inwomen, the long-term use of tamoxifen is associ-
ated with the secondary endometrial cancer [40]. Tamoxifen can cause
weight gain, sexual dysfunction, hot ﬂashes, thromboembolic events
and other clinical events in male patients [41]. These severe
tamoxifen-related side effects resulted in a high discontinuation rate
of the treatment in the patients [41]. Our study demonstrates that ta-
moxifen induces hernia formation in male mice suggesting another
side effect of tamoxifen to males selectively.
A few hernia models have been established with small or large
animals. The small animals are more accessible for standard animal
facilities and less expensive than large animals. They can be used
for setup of chemical or genetic hernia models. Estrogen or its ana-
logs induce mouse scrotal and inguinal hernias at a low incident
Fig. 7. Induction ofMMP-13 expression by tamoxifen is related to activation of JNK and ERK1/2 signaling pathways. A, C: NIH3T3 cells were treatedwith tamoxifen for the indicated times.
Expression of JNK and phospho-JNK (pi-JNK) (A), ERK1/2 and phospho-ERK1/2 (pi-ERK1/2) (C)was determined byWesternblot; B, D, E: NIH3T3 cellswere treatedwith tamoxifen or plus
SP600125 (SP), U0126 (U0) or both as indicated for 8 h followed by determination of MMP-13 expression by Western blot.
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β-Aminopropionitrile (BAPN), a lathyrogenic agent, can potently inhibit
lysyl oxidase to prevent formation of inter- and intramolecular cross
links in newly synthesized collagen and make collagen more soluble.Fig. 8. Tamoxifen induces MMP-2 expression by activating ERK1/2 signaling pathway. A, B: NIH
tamoxifen for the indicated times. Expression of MMP-2mRNA (A) and protein (B) was determ
NIH3T3 cells were treated with tamoxifen for 12 h. The treatment medium was collected and
tamoxifen or plus U0126 (U0) or SP600125 (SP) as indicated for 8 h followed by determinatioAdministration of BAPN or feeding Lathyrus odoratus seed to rats can in-
duce hernia formation [42,43]. However, BAPN alone induced inguinal
hernia formation at a very low rate. Thus, administration of BAPN
must be combined with enlarging the internal ring of the peritoneal3T3 cells were treatedwith tamoxifen at the indicated concentrations for 8 h or with 2 μM
ined by real time RT-PCR andWestern blot, respectively. *: vs. control, P b 0.05 (n= 3); C:
used to determine MMP-2 activity by zymography; D, E: NIH3T3 cells were treated with
n of MMP-2 expression by Western blot.
Fig. 9. High-fat diet and deﬁciency of apoE expression accelerate tamoxifen-induced occurrence of hernia. Male C57BL/6 wild type mice (A, Groups 1–4) and apoE deﬁcient (apoE−/−)
mice (B, Groups 5–8) were divided into 4 groups (10 mice/group) and received following treatment: Groups 1 and 5: normal chow; Groups 2 and 6: normal chow containing tamoxifen
(2mg/100 g food); Groups 3 and 7: high-fat diet (0.5% cholesterol and 21% fat, HFD); and Groups 4 and 8: HFD containing tamoxifen (2mg/100 g food), respectively, for 5 weeks. During
the treatment, all the animalswere daily checked and recorded the occurrence of hernia. At the end of experiment, all themicewere euthanized followed by autopsy and photograph. A, B:
the representative images of anatomical results fromeachgroup. Area of hernia occurrencewas labeled by red circles. The red and yellowarrows indicate the herniated out large and small
intestines, respectively; C: hernia formation inmice (10mice/group)with time of tamoxifen treatment. Triangles:malewild typemice in Group 2 (empty) andGroup 4 (ﬁlled) on normal
chow and HFD, respectively; Circles: male apoE−/−mice in Group 6 (empty) and Group 8 (ﬁlled) on normal chow and HFD, respectively. HFD accelerates tamoxifen-induced hernia
formation (Group 4 vs. Group 2; Group 8 vs. Group 6); deﬁciency of apoE expression also accelerates tamoxifen-induced hernia formation (Group 6 vs. Group 2; Group 8 vs. Group 4).
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L. odoratus to rats can increase the incidence rate of hernia to 50% but
it may cause changes in other tissues [44]. In contrast, administrationof tamoxifen induces hernia formation at 100% incidence rate without
other obvious side effects which suggests that this model is safe and
reliable. Although it is not easy to perform anoperation for hernia repair
1048 X. Ma et al. / Biochimica et Biophysica Acta 1852 (2015) 1038–1048on amousemodel, the studywithmice can advance the understandings
of biological mechanisms for hernia development. The ﬁndings with
animal study can also provide beneﬁts for management of hernia. For
example, the mesh coated with a controlled-release MMP inhibitor may
further prevent the recurrence of hernias. However, more investigation
should be completed since the large anatomical difference between
animals and humans may limit the application of basic research results
to humans.
In summary, currently tamoxifen is used for treatment of female
breast cancer patients. However, the pleiotropic effects suggest that
tamoxifenmay be used for bothmale and female patients for treatment
of other diseases, such as cardiovascular disease, for a long-term use.
Therefore, in addition to the establishment of a hernia model with a
reliable and convenient method, our study unveils a severe side effect
of tamoxifen and suggests a caution to male patients for a long-term
use.
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